MarketCap
Facebook
X
TelegramQuartalsbericht 2024-Q1
hinzugefügt 14.05.2024
Acorda Therapeutics ROE 2011-2026 | ACOR
ROE Jährlich Acorda Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 160.08 | -70.41 | -68.78 | -41.85 | -87.82 | 5.5 | -42.95 | -5.21 | 1.83 | 3.27 | 3.73 | 40.15 | 14.91 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 160.08 | -87.82 | -6.73 |
ROE Vierteljährlich Acorda Therapeutics
| 2024-Q1 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -43.68 | -111.54 | -90.61 | -107.07 | -105.25 | -64.15 | -44.68 | -41.59 | -22.04 | -17.36 | -6.95 | 14.17 | -73.7 | -75.23 | -87.82 | -107.38 | -24.86 | -8.47 | 5.35 | -29.11 | -31.69 | -40.81 | -42.95 | -10.52 | -7.63 | -8.88 | -5.32 | -3.33 | -0.69 | 2.3 | 1.87 | 0.4 | 1.93 | 2.63 | 3.27 | 4.62 | 4.1 | 4.12 | 3.73 | 36.78 | 37.57 | 37.86 | 40.15 | 11.88 | 18.59 | 17.27 | 14.91 | 9.19 | -0.14 | -0.33 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 40.15 | -111.54 | -18.82 |
ROE anderer Aktien in der Pharmaeinzelhändler
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Apellis Pharmaceuticals
APLS
|
6.05 | $ 20.36 | -1.64 % | $ 2.57 B |  USA |
 |
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M |  Germany |
 |
Aptorum Group Limited
APM
|
-20.19 | $ 0.81 | -4.23 % | $ 4.42 M |  China |
 |
Axsome Therapeutics
AXSM
|
-207.46 | $ 164.64 | -1.05 % | $ 8.19 B | USA |
 |
I-Mab
IMAB
|
-85.31 | - | - | $ 866 M | China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M |  France |
 |
AbCellera Biologics
ABCL
|
-15.14 | $ 3.7 | -3.27 % | $ 1.11 B |  Canada |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
-330.29 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Burford Capital Limited
BUR
|
10.1 | $ 8.53 | -2.35 % | $ 1.39 B | Britain |
 |
Corvus Pharmaceuticals
CRVS
|
-69.87 | $ 18.0 | 0.61 % | $ 864 M | USA |
 |
Adverum Biotechnologies
ADVM
|
-185.15 | - | - | $ 86.2 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - |  Russia |
 |
Certara
CERT
|
-0.15 | $ 7.28 | 3.19 % | $ 1.17 B | USA |
 |
ARCA biopharma
ABIO
|
-21.9 | - | 1052.0 % | $ 415 M | USA |
 |
Acer Therapeutics
ACER
|
156.54 | - | 2.71 % | $ 14 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-32.19 | - | - | $ 2.17 B | USA |
 |
Capricor Therapeutics
CAPR
|
-98.61 | $ 26.28 | -2.16 % | $ 704 M | USA |
 |
Acasti Pharma
ACST
|
-14.36 | - | 4.01 % | $ 150 M | Canada |
 |
Codexis
CDXS
|
-97.53 | $ 1.01 | -0.49 % | $ 74.1 M | USA |
 |
CureVac N.V.
CVAC
|
-59.8 | - | - | $ 867 M | Germany |
 |
Catalyst Pharmaceuticals
CPRX
|
22.46 | $ 23.89 | 0.04 % | $ 2.92 B | USA |
 |
Aeterna Zentaris
AEZS
|
-401.79 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
-270.67 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-21.7 | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
-62.37 | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
-36.89 | - | 1.93 % | $ 17.4 M | USA |
 |
Agenus
AGEN
|
160.57 | $ 3.22 | -3.59 % | $ 1.15 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
3458.87 | - | - | $ 7.46 M |  Israel |
 |
Akero Therapeutics
AKRO
|
-33.6 | - | - | $ 3.67 B | USA |
 |
Agios Pharmaceuticals
AGIO
|
-34.6 | $ 28.92 | -0.96 % | $ 1.68 B | USA |
 |
Champions Oncology
CSBR
|
124.63 | $ 5.98 | -1.48 % | $ 81.7 M | USA |
 |
Advaxis
ADXS
|
196.88 | - | -9.65 % | $ 45.9 M | USA |
 |
Akouos
AKUS
|
-37.09 | - | 0.23 % | $ 488 M | USA |
 |
Завод ДИОД
DIOD
|
3.1 | - | - | - | Russia |
 |
Фармсинтез
LIFE
|
-51.75 | - | - | - | Russia |
 |
Albireo Pharma
ALBO
|
-19.38 | - | -0.23 % | $ 916 M | USA |
 |
Cellectis S.A.
CLLS
|
-26.25 | $ 3.68 | -3.16 % | $ 116 M | France |
 |
Alector
ALEC
|
-466.34 | $ 2.13 | -3.62 % | $ 219 M | USA |
 |
KalVista Pharmaceuticals
KALV
|
-192.31 | $ 15.77 | -1.81 % | $ 783 M | Britain |
 |
Allena Pharmaceuticals
ALNA
|
-257.91 | - | 3.16 % | $ 1.9 M | USA |
 |
Aileron Therapeutics
ALRN
|
-115.61 | - | 10.36 % | $ 9.8 M | USA |
 |
Altimmune
ALT
|
-76.97 | $ 4.25 | 2.04 % | $ 302 M | USA |
 |
Teligent, Inc.
TLGT
|
473.41 | - | -13.85 % | $ 16.1 M | USA |
 |
AlloVir
ALVR
|
-51.87 | - | 4.14 % | $ 49.1 M | USA |
 |
Viela Bio, Inc.
VIE
|
-40.09 | - | - | $ 2.91 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-256.9 | - | -11.43 % | $ 502 K | USA |
 |
Amarin Corporation plc
AMRN
|
-8.45 | $ 14.2 | 1.9 % | $ 5.89 B |  Irlanda |